Sharemaestro Newsreel

Cigna (CI) Stock Stalls As Evernorth Carries Growth And PBM Pressure Builds

Cigna's stock experienced a slight dip despite strong Q2 2026 earnings, with adjusted EPS guidance lifted to at least US$30.45. Growth is primarily driven by its Evernorth segment, particularly specialty pharmacy and care services, which are boosting margins. However, concerns remain regarding pressure on …

Elevance Health Number of Employees 2026 | Employee Count & Headcount Data

Elevance Health (ELV) had approximately 96,975 employees worldwide as of March 2026, representing an 8.8% decline since 2023. The company's workforce is primarily concentrated in the United States, India, and the Philippines, with Puerto Rico being its fastest-growing location. Elevance Health is actively hiring, …

The Cigna Group Revenue Breakdown – NYSE:CI

Healthcare Services Group (NASDAQ:HCSG) Cut to "Hold" at Wall Street Zen

Wall Street Zen downgraded Healthcare Services Group (NASDAQ:HCSG) from "Buy" to "Hold," despite the broader analyst consensus remaining a "Moderate Buy" with a $26.20 average price target. The company recently reported strong quarterly EPS of $0.32, surpassing the $0.22 consensus, with revenue largely meeting …

Wells Fargo Adjusts Price Target on Cigna Group to $307 From $305, Maintains Equalweight Rating

Wells Fargo has increased its price target for The Cigna Group (CI) from $305 to $307, while reiterating an Equalweight rating on the stock. This minor adjustment reflects a continued neutral stance on the company's valuation and future performance.

Alignment Healthcare (ALHC) Stock Sinks As Legal Risks Cloud Margin Gains

Alignment Healthcare (ALHC) experienced a significant stock drop despite showing improved Q2 2026 earnings, including a 32% revenue increase and better adjusted medical benefit and EBITDA margins. The market's reaction is attributed to ongoing legal risks, such as a whistleblower lawsuit and securities investigations, …

(OSCR) Risk Channels and Responsive Allocation

This article provides an AI-driven analysis for Oscar Health Inc. Class A (NASDAQ: OSCR), highlighting positive near-term sentiment within a long-term strength context. It details institutional trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for support and …

Cigna Group stock underperforms Friday when compared to competitors

Cigna Group (CI) stock declined by 2.99% on Friday, closing at $279.05, despite a positive trading session for the broader market. Both the S&P 500 Index and the Dow Jones Industrial Average saw gains. This marks the third consecutive day of losses for Cigna …

UnitedHealth Group stock steadies as earnings and cyberattack fallout reshape outlook

UnitedHealth Group's stock remains stable as investors assess strong earnings against persistent costs from the Change Healthcare cyberattack and increased regulatory scrutiny of its Optum unit. Despite cyberattack-related expenses, the company reported consolidated revenue exceeding $100 billion in the recent quarter and maintained positive …

Alphatime Acquisition Corp Announces Board and Committee Changes, Effective July 28, 2026

Alphatime Acquisition Corp announced board and committee changes effective July 28, 2026. Li Wei and Michael Coyne resigned from the Board of Directors and their respective committees. Concurrently, Mr. Pua Chee Aun and Mr. Lee Seongil were appointed as Class II and Class III …

Cigna spent $370M on severance in the first half of the year

Cigna incurred $370 million in severance costs during the first half of 2026, stemming from operational efficiency initiatives announced in May 2025. This figure is significantly higher than the $194 million spent on severance in the first half of 2025. Additionally, the company has …

Vanguard Portfolio Management (ALHC) reports 11.9M-share Alignment Healthcare stake

Vanguard Portfolio Management LLC has reported a significant stake in Alignment Healthcare Inc. (ALHC), holding 11,874,585 shares, which represents 5.74% of the outstanding common stock. This disclosure, made via a SCHEDULE 13G filing, indicates Vanguard has sole dispositive power over all these shares and …

CI Maintained by Wells Fargo -- Price Target Raised to $307

Wells Fargo has maintained an Equal-Weight rating for Cigna Group (CI), raising its price target slightly from $305.00 to $307.00. The stock appears undervalued based on its P/E ratio, but its GF Score of 47/100 and significant insider selling suggest a cautious outlook for …

CI Maintained by Guggenheim -- Price Target Raised to $361

Guggenheim has maintained a Buy rating for Cigna Group (CI) and raised its price target to $361.00, reflecting confidence in the company's future earnings. Despite this positive analyst outlook, the company's GF Score of 47/100 indicates moderate performance with strong profitability but challenges in …

Alignment Healthcare boasts 32% revenue jump in Q2, lifts 2026 outlook

Alignment Healthcare reported a significant 31.6% revenue increase to $1.34 billion in Q2 2026, exceeding analyst expectations. The company attributed this strong performance to its new AI-powered stratification model, which helps predict hospitalizations and optimize care. Alignment also raised its 2026 forecast, projecting membership …

Humana Targets ’27 Plan Exits Affecting About 600,000 People

Humana plans to shed approximately 600,000 members in 2027 by exiting certain markets and concentrating on higher-profitability insurance plans, many of which utilize value-based care. This strategic move aims to improve the company's margins, even as it faces rising treatment and drug costs. CEO …

Cigna (CI) Stock Could Still Be Cheap After Strong Results

Cigna Group (CI) stock has shown a 53.0% total return over the past five years and appears undervalued based on current valuation checks, including a P/E ratio significantly below industry averages. Despite strong recent results and expanded AI-enabled healthcare programs, the market seems to …

Cigna Group Price Target Raised to $310.00/Share From $304.00 by Barclays

Barclays has increased its price target for Cigna Group (NYSE:CI) to $310.00 per share, up from $304.00. This adjustment reflects a continued positive outlook on the company's financial performance by the analyst firm.

SummitTX Capital L.P. Invests $834,000 in Humana Inc. $HUM

SummitTX Capital L.P. recently acquired a new position in Humana Inc. (NYSE:HUM) valued at approximately $834,000. Several other institutional investors also adjusted their holdings in Humana, with 92.38% of the stock owned by institutional investors. The article details Humana's recent earnings, price performance, and …

Kentucky Retirement Systems Increases Stock Position in Humana Inc. $HUM

Kentucky Retirement Systems significantly increased its stake in Humana Inc. by 69.8% in the first quarter of 2026, bringing its total holdings to 12,872 shares valued at approximately $2.23 million. This move comes as Humana exceeded second-quarter revenue and adjusted EPS expectations, although its …

Healthcare Services Group, Inc. (NASDAQ:HCSG) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Healthcare Services Group, Inc. (NASDAQ:HCSG) has received an average recommendation of "Moderate Buy" from eight research firms, with three holding and five buy ratings. Analysts have set an average 12-month price target of $26.20 for the stock. The company recently reported Q2 EPS of …

Alignment Healthcare (NASDAQ: ALHC) raises 2026 outlook after Q2 revenue jump

Alignment Healthcare (ALHC) reported strong Q2 2026 results, with total revenue increasing by 31.6% year-over-year to $1,335.6 million and health plan membership growing by 31.5% to approximately 294,100. The company surpassed its guidance across key metrics, achieving adjusted EBITDA of $68.1 million and net …

Elevance Health (NYSE:ELV) Releases FY 2026 Earnings Guidance

Humana (HUM) Stock Stays Calm As Margin Repair Starts To Show

CVS Health (CVS) Draws Earnings Buzz, Is 6% Undervalued Enough?

Alignment Healthcare, Inc. Quarterly Earnings Report

Alignment Healthcare, Inc. (ALHC) reported its quarterly earnings, with a net income of $36.56 million for the quarter ended June 30, 2026, and $47.98 million for the six months ended June 30, 2026. The company experienced significant growth in Health Plan membership, reaching 294,100 …

Certain Class B Ordinary Shares of VisionSys AI Inc. are subject to a Lock-Up Agreement Ending on 31-JUL-2026.

Certain Class B Ordinary Shares of VisionSys AI Inc. are under a lock-up agreement set to expire on July 31, 2026. This agreement, spanning 121 days from April 1, 2026, prevents executive officers, directors, and significant shareholders from selling or transferring their shares. The …

Elevance Health’s CEO started her career as a pro basketball player. Now she’s the highest‑ranking woman on the Global 500, leading a $199B giant

Gail Boudreaux, CEO of Elevance Health, is the highest-ranking woman on the Fortune Global 500, leading a $199 billion company. Her career began as a professional basketball player in France, an experience she credits with shaping her leadership style focused on teamwork and risk-taking. …

Alignment Healthcare: Q2 Earnings Snapshot

Alignment Healthcare (ALHC) reported strong second-quarter results, with earnings of $36.6 million, or 17 cents per share, surpassing Wall Street expectations of 13 cents per share. The Medicare Advantage insurer also exceeded revenue forecasts, posting $1.34 billion against an expected $1.31 billion. Despite a …

Centene Corp (CNC) Institutional Confidence

Centene Corp (CNC) has an institutional shareholding score of 10.00, placing it first in the Healthcare Providers & Services industry. Its institutional shareholding proportion is 98.34%, with David G. Herro being the largest individual institutional shareholder. Major institutional holders include AQR Capital Management, BlackRock, …

Elevance accuses Hamaspik of poaching staff to copy its plans

Elevance Health has filed a lawsuit against Hamaspik, Inc. and four former employees, alleging a "coordinated scheme" to poach key staff and steal confidential files related to Elevance's Medicare-Medicaid plans. Elevance claims Hamaspik hired at least seven former employees, some of whom allegedly emailed …

Transcript : DexCom, Inc., Q2 2026 Earnings Call, Jul 30, 2026

This article provides a transcript of DexCom, Inc.'s Q2 2026 Earnings Call held on July 30, 2026. The company also announced an increase in its earnings guidance for the fiscal year 2026. Access to the full transcript requires a MarketScreener subscription.

Alignment Healthcare, Inc. (ALHC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Alignment Healthcare, Inc. (ALHC) following allegations of accounting irregularities that "artificially inflated" the company's financial results. A whistleblower complaint suggests "millions of dollars in operating expenses had been systematically misclassified as capital expenditures," leading …

The Cigna Group Reports Strong Second Quarter 2026 Results, Raises 2026 Outlook

The Cigna Group announced strong second-quarter 2026 results, with total revenues increasing 7% to $71.7 billion and adjusted income from operations reaching $2.1 billion, or $7.78 per share. The company raised its full-year 2026 outlook for adjusted income from operations to at least $30.45 …

Alignment Healthcare, Inc. (ALHC) Q2 2026 Earnings

Alignment Healthcare, Inc. (ALHC) reported its Q2 2026 earnings, missing EPS estimates by 16% with $0.17 against an estimated $0.20, despite a 48% jump in adjusted EBITDA. The company beat revenue expectations by 2%, reaching $1.34 billion, driven by a 31.5% membership surge. ALHC …

Cigna reports more AI, more health customers and more profit in strong Q2

Cigna reported strong second-quarter results, driven by its Evernorth health services and Cigna Healthcare insurance operations, with President and CEO Brian C. Evanko highlighting investments in AI and personalized healthcare for future growth. The company saw a 2% increase in medical customers but a …